The thought behind vaccines is different now than it used to be. It is now just like all the other drugs they bring on the market. Most of them with terrible side effects and then pulled off the shelves a few years later. Pharma companies will be bringing out vaccines for every imaginable thing soon. They have it made, now you are a typhod Mary if you dont get your vaccine for this and that. And the CDC and the WHO play right into their hands. The vaccine for polio and other diseases were life savers. But vaccines for everything is going to be very dangerous. Here is a story from AP yesterday.
MARIETTA, Pa. — Malaria. Tuberculosis. Alzheimer's disease. AIDS. Pandemic flu. You name it, the pharmaceutical industry is working on a vaccine to prevent it.
Many could be on the market in five years or less.
Contrast that with five years ago, when so many companies had abandoned the vaccine business that half the U.S. supply of flu shots was lost because of contamination at one of the two manufacturers left.
Vaccines are no longer a low-profit niche in a booming drug industry. They're starting to give ailing pharmaceutical makers a shot in the arm.
The lure of big profits, advances in technology and growing government support has been drawing in new companies, from nascent biotechs to Johnson & Johnson. That means recent remarkable strides in overcoming dreaded diseases and annoying afflictions likely will continue.
"Even if a small portion of everything that's going on now is successful in the next 10 years, you put that together with the last 10 years (and) it's going to be characterized as a golden era," says Emilio Emini, Pfizer's head of vaccine research.
Vaccines now are viewed as a crucial path to growth, as drugmakers look for ways to bolster slowing prescription-medicine sales amid intensifying generic competition and government pressure to cut down prices under the federal health overhaul.
Unlike medicines that treat diseases, vaccines help prevent infections by revving up the body's natural immune defenses against invaders.
Investment in partnerships and other deals to develop and manufacture vaccines has been on a tear — and accelerating since the swine-flu pandemic began. Billions in government grants are bringing better, faster ways to develop and manufacture vaccines.
"What was essentially 25 years ago a rounding error now has become real money," said Robin Robertson, director of the U.S. Biomedical Advanced Research Development Authority.
That jump is because of a couple of new blockbuster vaccines and rising use of existing ones. The government's list of recommended vaccines for children has more than doubled since 1985 to 17.